Last edition
News about "Ascidian Therapeutics "
Ascidian Therapeutics Completes STELLAR Trial Dose Escalation for ACDN-01 in Stargardt Disease
Ascidian Therapeutics completes Phase 1/2 STELLAR dose escalation for ACDN-01 in Stargardt disease, advances pediatric enrollment, and launches STARPATH prescreening to accelerate clinical trial access.
Ascidian Therapeutics | 05/05/2026 | By News Bureau | 232
Ascidian Partners with Roche for Development of RNA Exon Editing Therapeutics
Ascidian Therapeutics has signed a research collaboration and licensing agreement with Roche for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.
Ascidian Therapeutics | 19/06/2024 | By Aishwarya | 480
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy